Related Experiment Video
Updated: Jul 3, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Breast Cancer Screening in the Intermediate-Risk Population: Falling Through the Cracks?
Kaitlin M Zaki-Metias1, Huijuan Wang1, Tima F Tawil1
1Department of Radiology, Trinity Health Oakland Hospital/Wayne State University School of Medicine, Pontiac, MI, USA.
Abstract:
Breast cancer screening guidelines vary for women at intermediate risk (15%-20% lifetime risk) for developing breast cancer across jurisdictions. Currently available risk assessment models have differing strengths and weaknesses, creating difficulty and ambiguity in selecting the most appropriate model to utilize. Clarifying which model to utilize in individual circumstances may help determine the best screening guidelines to use for each individual.
Related Concept Videos
Cancer Prevention
Some...
Preventive Healthcare Services
Cancer Prevention
Some...
Relative Risk

